Search Within

Martin Stuart Tallman

  1. "Ferrata Storti Foundation"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (9)
  3. Research Letter (3)
Groups
  1. Adult Leukemia (24)
  2. Center for Hematologic Malignancies (24)
  3. Department of Medicine (24)
  4. Hematologic Malignancies, Division of (24)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (8)
  6. Executive Committee, Center for Hematologic Malignancies (8)

More Groups

People
  1. Ross Levine (7)
  2. Sean Devlin (6)
  3. Eytan Stein (5)
  4. Raajit Rampal (4)
  5. Jae Park (3)
  6. Omar Abdel-Wahab (3)

More People

Years
  1. 2025 (1)
  2. 2022 (1)
  3. 2021 (1)
  4. 2020 (3)
  5. 2019 (2)
  6. 2018 (1)

More Years

Publications
  1. Haematologica (24)
Publishers
  1. Ferrata Storti Foundation (24)

Results (24)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early death and intracranial hemorrhage prediction in acute promyelocytic leukemia: Validation of a risk score in a cohort from an international consortium treated with chemotherapy plus all-trans retinoic acid
    Research Letter

    Silva, W. F.; Kim, H. T.; Undurraga, M. S.; Navarro-Cabrera, J. R.; Salinas, V.; Muxi, P.; Melo, R. A. M.; Gloria, A. B. F.; Pagnano, K. B. B.; Nunes, E. C.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • A phase I study of the fully human, fragment crystallizable-engineered, anti-CD-33 monoclonal antibody BI 836858 in patients with previously-treated acute myeloid leukemia
    Research Letter

    Vasu, S.; Altman, J. K.; Uy, G. L.; Tallman, M. S.; Gojo, I.; Lozanski, G.; Burkard, U.; Osswald, A.; James, P.; Rüter, B.; more...
    Haematologica (2022)

    Fulltext@MSK | Save
  • Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of minimal residual disease negativity in adults up to age 60 with Philadelphia chromosome-negative acute lymphoblastic leukemia
    Journal Article

    Geyer, M. B.; Ritchie, E. K.; Rao, A. V.; Vemuri, S.; Flynn, J.; Hsu, M.; Devlin, S. M.; Roshal, M.; Gao, Q.; Shukla, M.; more...
    Haematologica (2021)

    Fulltext@MSK | Save
  • Venetoclax as monotherapy and in combination with hypomethylating agents or low dose cytarabine in relapsed and treatment refractory acute myeloid leukemia: A systematic review and meta-analysis
    Research Letter

    Bewersdorf, J. P.; Giri, S.; Wang, R.; Williams, R. T.; Tallman, M. S.; Zeidan, A. M.; Stahl, M.
    Haematologica (2020)

    Fulltext@MSK | Save
  • Oral arsenic trioxide ORH-2014 pharmacokinetic and safety profile in patients with advanced hematologic disorders
    Journal Article

    Ravandi, F.; Koumenis, I.; Johri, A.; Tallman, M.; Roboz, G. J.; Strickland, S.; Garcia-Manero, G.; Borthakur, G.; Naqvi, K.; Meyer, M.; more...
    Haematologica (2020)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia: Results from an international collaborative study
    Journal Article

    Kayser, S.; Hills, R. K.; Luskin, M. R.; Brunner, A. M.; Terré, C.; Westermann, J.; Menghrajani, K.; Shaw, C.; Baer, M. R.; Elliott, M. A.; more...
    Haematologica (2020)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia
    Journal Article

    Xiao, W.; Goldberg, A. D.; Famulare, C. A.; Devlin, S. M.; Nguyen, N. T.; Sim, S.; Kabel, C. C.; Patel, M. A.; McGovern, E. M.; Patel, A.; more...
    Haematologica (2019)

    Fulltext@MSK | Save
  • Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: A subset analysis from ECOG-ACRIN 1900
    Journal Article

    Fernandez, H. F.; Sun, Z.; Litzow, M. R.; Luger, S. M.; Paietta, E.; Racevskis, J.; Levine, R. L.; Patel, J. P.; Abdel-Wahab, O.; Ketterling, R. P.; more...
    Haematologica (2019)

    Fulltext@MSK | Save
  • Hsp90 inhibition disrupts JAK-STAT signaling and leads to reductions in splenomegaly in patients with myeloproliferative neoplasms
    Journal Article

    Hobbs, G. S.; Hanasoge Somasundara, A. V.; Kleppe, M.; Litvin, R.; Arcila, M.; Ahn, J.; McKenney, A. S.; Knapp, K.; Ptashkin, R.; Weinstein, H.; more...
    Haematologica (2018)

    Fulltext@MSK | Save
  • Variant FLT3 mutations can be eradicated by cytarabine/anthracycline/crenolanib induction in adult patients with newly diagnosed FLT3 (ITK/TKD) mutant AML
    Meeting Abstract

    Wang, E.; Stone, R.; Collins, R.; Agrawal, T.; Urity, V.; Tallman, M.
    Haematologica (2017)

    Fulltext@MSK | Save